Information about Haldol Decanoate
Haldol Decanoate is a long-acting injectable formulation of haloperidol, an antipsychotic medication. It is primarily used for the treatment of schizophrenia and other chronic psychiatric disorders, providing sustained medication levels in the body to improve compliance and reduce the frequency of administration.
Product Highlights
- Used for the treatment of patients with schizophrenia to stabilize mood and reduce psychotic symptoms.
- Effective for individuals with chronic psychiatric conditions requiring long-term treatment.
Key Ingredient
Key Benefits
- Provides a steady release of haloperidol, leading to more stable symptom control.
- Helps manage symptoms, allowing for better daily functioning and quality of life for patients.
- Typically administered every 3 to 4 weeks, which is beneficial for patients with challenges related to daily medication adherence.
Direction of Use
- Administered intramuscularly by a healthcare professional, often in the gluteal muscle.
- The initial dose is typically based on the patient’s prior oral haloperidol dosage and adjusted according to clinical response.
- Regular follow-up appointments are necessary to evaluate efficacy and adjust the dose if needed.
Safety Concerns
- May include sedation, weight gain, extrapyramidal symptoms (e.g., tremors, rigidity), and dry mouth.
- Potential for QT interval prolongation; periodic ECG monitoring may be advised.
- A rare but severe reaction that may occur, characterized by high fever, muscle rigidity, and altered mental status.
Avoid Haldol Decanoate (Haloperidol) If
- Known allergy to haloperidol or any components of the formulation.
- Contraindicated in patients with Parkinson’s disease or conditions characterized by significant dopamine depletion.
- Caution is advised for patients with severe depression due to the risk of exacerbating symptoms.
- Not to be used in patients who are comatose or experiencing severe central nervous system depression.
